Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
9.60
+0.11 (1.16%)
Dec 5, 2025, 4:00 PM EST - Market closed
Anika Therapeutics Employees
Anika Therapeutics had 288 employees as of December 31, 2024. The number of employees decreased by 69 or -19.33% compared to the previous year.
Employees
288
Change (1Y)
-69
Growth (1Y)
-19.33%
Revenue / Employee
$391,688
Profits / Employee
-$114,712
Market Cap
138.44M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ANIK News
- 4 weeks ago - Anika Therapeutics, Inc. (ANIK) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Anika Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025 - GlobeNewsWire
- 2 months ago - ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Anika Therapeutics Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Anika Stockholders - GlobeNewsWire
- 3 months ago - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Anika Therapeutics: Undervalued HA Platform With 2027 Catalysts - Seeking Alpha
- 4 months ago - Anika (ANIK) Q2 Revenue Beats by 4% - The Motley Fool
- 4 months ago - Anika Therapeutics, Inc. (ANIK) Q2 2025 Earnings Call Transcript - Seeking Alpha